Balance Sheet StrengthZero debt materially lowers financial risk and gives the company durable resilience through cycles. This conservative capital structure preserves optionality for R&D, M&A, dividends or buybacks, and reduces refinancing risk, supporting long-term stability.

Stable Gross MarginsConsistently high gross margins point to durable product economics and pricing power in diagnostics consumables and instruments. Stable margins support operating profitability and cash generation even if revenue growth is uneven, underpinning sustainable earnings.

Strong Cash ConversionFree cash flow that tracks net income closely indicates high earnings quality and the ability to self-fund operations, capex and distributions. Reliable cash conversion enhances financial flexibility and funds strategic investments without adding leverage.

Bears Say

Recent Revenue DeclineA YoY revenue decline signals weakening top-line momentum and raises questions about demand, product mix or competitive pressure. Sustained rollbacks in sales can erode scale advantages, reduce operating leverage, and constrain long-term growth prospects.

Margin CompressionA notable drop in net margin reduces retained earnings and free cash flow available for reinvestment. If caused by structural mix shifts or rising costs, compression can persist, weakening returns on capital and limiting the company's ability to expand margins sustainably.

Uneven Cash GenerationVolatile free cash flow and modest operating cash flow relative to sales raise concerns about working-capital swings or inconsistent execution. This variability can complicate planning for capex, R&D and distributions, elevating operational and financial unpredictability.

Techno Medica Co., Ltd. News

Techno Medica posts higher nine-month earnings and keeps FY dividend plan

Techno Medica Co., Ltd. ( ($JP:6678) ) has shared an update. For the nine months to December 31,...

12d ago

6678

Techno Medica Reports Stable Financial Position Amid Slight Profit Decline

An update from Techno Medica Co., Ltd. ( ($JP:6678) ) is now available. Techno Medica Co., Ltd. reported...

3M ago

6678

Techno Medica Reports Decline in Fiscal Year 2025 Financial Results

Techno Medica Co., Ltd. ( ($JP:6678) ) has shared an update. Techno Medica Co., Ltd. reported a decline...

9M ago

6678

Techno Medica Reports Nine-Month Financial Results with Profit Decline

Techno Medica Co., Ltd. ( ($JP:6678) ) has issued an announcement. Techno Medica Co., Ltd. reported its non-consolidated...

1y ago

6678

Techno Medica Reports Mixed Financial Results

Techno Medica Co., Ltd. (JP:6678) has released an update. Techno Medica Co., Ltd. reported a slight increase in...

1y ago

6678

Techno Medica Reports Strong Quarter, Maintains Dividend

Techno Medica Co., Ltd. (JP:6678) has released an update. Techno Medica Co., Ltd. reported a strong financial performance...

2y ago

6678

6678 FAQ

What was Techno Medica Co., Ltd.’s price range in the past 12 months?

Techno Medica Co., Ltd. lowest stock price was ¥1580.00 and its highest was ¥2599.00 in the past 12 months.

What is Techno Medica Co., Ltd.’s market cap?

Techno Medica Co., Ltd.’s market cap is ¥21.89B.

When is Techno Medica Co., Ltd.’s upcoming earnings report date?

Techno Medica Co., Ltd.’s upcoming earnings report date is May 13, 2026 which is in 86 days.

How were Techno Medica Co., Ltd.’s earnings last quarter?

Techno Medica Co., Ltd. released its earnings results on Feb 04, 2026. The company reported ¥37.13 earnings per share for the quarter, beating the consensus estimate of N/A by ¥37.13.

Is Techno Medica Co., Ltd. overvalued?

According to Wall Street analysts Techno Medica Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Techno Medica Co., Ltd. pay dividends?

Techno Medica Co., Ltd. pays a Annually dividend of ¥68 which represents an annual dividend yield of 3.02%. See more information on Techno Medica Co., Ltd. dividends here

What is Techno Medica Co., Ltd.’s EPS estimate?

Techno Medica Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Techno Medica Co., Ltd. have?

Techno Medica Co., Ltd. has 8,760,000 shares outstanding.

What happened to Techno Medica Co., Ltd.’s price movement after its last earnings report?

Techno Medica Co., Ltd. reported an EPS of ¥37.13 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.143%.

Which hedge fund is a major shareholder of Techno Medica Co., Ltd.?

Currently, no hedge funds are holding shares in JP:6678

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Techno Medica Co., Ltd.

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers test tube preparation, automatic urine aliquot, RFID specimen management, and RFID blood transfusion management, as well as blood gas, electrolyte, Erythrocyte Sedimentation Rate, nutrient, sugar and acid, and urine chemistry analyzers; electronic medical charts and pre-analytical instruments; and consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.